Parliamentarians Demand End to "Blind Approval" of Animal Testing Amidst Growing Ethical Concerns
London, UK – A significant parliamentary movement is gaining momentum, calling on the UK government to dismantle the system of "blind approval" for animal testing. A recent motion, Early Day Motion (EDM) 465, has garnered cross-party support, urging a fundamental shift away from current licensing practices that critics argue lack transparency and accountability, leading to the unnecessary suffering of sentient beings.
At the time of reporting, EDM 465 has been endorsed by 27 Members of Parliament (MPs), including six who have sponsored the motion and 21 who have signed on as signatories. Introduced at the close of June by Neil Duncan-Jordan, the Labour MP for Poole, the motion represents a growing chorus of voices within Westminster demanding greater scrutiny and a more ethical approach to scientific procedures involving animals.
The core of the parliamentary concern, as highlighted by the British animal rights organization Animal Aid, lies in the practice of granting "generic service licenses." These licenses, according to Animal Aid, permit laboratories to conduct a broad category of animal tests without requiring specific details or justifications for each individual experiment. This perceived lack of granular oversight, critics contend, makes it virtually impossible to ascertain the true necessity and ethical justification for many animal tests conducted annually.
The Mechanics of "Blind Approval": A System Under Scrutiny
Freedom of Information (FOI) data obtained from the Home Office paints a stark picture of the scale of this practice. In the first three months of 2026 alone, six generic service licenses were issued. These broad authorizations granted permission for the use of over 100,000 animals in experimental procedures over the subsequent five years. This statistic underscores the significant number of animals whose fates are determined by these overarching licenses, raising serious questions about whether each individual procedure has undergone rigorous ethical review.
EDM 465 directly addresses these concerns by calling for a multi-pronged approach: an immediate cessation of all new generic service licenses, a comprehensive review of all existing licenses to ensure their continued justification, and the urgent implementation of the government’s own "Replacing Animals in Science Strategy." This strategy, published by the government, outlines a commitment to supporting the development, validation, and adoption of alternative methods to animal testing, suggesting an existing recognition of the need for change.
Voices from Westminster: A Call for Transparency and Accountability
The breadth of support for EDM 465 is notable, with signatories representing a diverse spectrum of the political landscape. Among the MPs lending their names to the motion are Irene Campbell (Labour), Hannah Spencer (Green Party), Jeremy Corbyn (formerly Labour, now an Independent), Manuela Perteghella (Liberal Democrats), Diane Abbott (Independent), and Seamus Logan (Scottish National Party). This cross-party consensus signals a potent, united front advocating for reform.
Neil Duncan-Jordan, the motion’s introducer, articulated the ethical imperative driving this parliamentary initiative with powerful words: "What we are witnessing is suffering hidden behind process and paperwork. Licences should never be issued in the dark," he stated. "When approval is ‘blind,’ so is accountability, and animals pay the price. Behind every licence is a living creature subjected to fear, distress, and suffering that the public is never allowed to see. That must change." His sentiment highlights the disconnect between the secretive nature of some licensing processes and the public’s growing demand for ethical scientific practices.
The Unseen Suffering: Animal Aid’s Campaign and Public Engagement
Animal Aid has been at the forefront of exposing the realities of animal testing in the UK. Their recent exposé, titled Toxicity Inc., launched in April, has evidently resonated with the public, prompting a significant wave of constituent engagement with MPs. The organization reports that over 20,000 individuals have contacted their parliamentary representatives in support of reforming the UK’s use of animal testing since the exposé’s release. This grassroots activism, channeled through direct communication with elected officials, has demonstrably influenced the parliamentary agenda.

The EDM 465 specifically acknowledges the pivotal role of Animal Aid in bringing this critical issue to the attention of MPs, recognizing their dedication to advocacy and research. Alex Harman, Animal Aid’s campaign manager, emphasized the urgency of transitioning away from outdated and unreliable methods: "The government must halt these unreliable toxicity tests now and immediately shift funding to superior, human-relevant alternatives like AI and advanced cell models. Thousands of animals experience suffering and eventual death due to toxicity tests," he urged.
Harman further encouraged the public to witness the evidence presented in the Toxicity Inc. exposé, stating, "I’d highly encourage anyone who reads this to watch the exposé at toxicity.inc and see the truth for yourself." This call to action underscores the organization’s commitment to transparency and its belief that public awareness is a crucial catalyst for change.
A Slow Transition: Government Pledges Versus Reality
While the UK government has publicly committed to transitioning away from animal testing, the pace of this progress is a growing source of frustration for animal welfare advocates and a significant portion of the scientific community. Despite the availability of numerous alternative methods – many of which are well-established, more cost-effective, and ethically superior – the shift remains notably slow.
Recent statistics released by the Home Office reveal a stark reality. For the period between 2024 and 2025, there was an overall decrease in animal testing of just four percent. More concerningly, the same period saw an increase in the use of dogs, cats, monkeys, and horses in experimental procedures. This trend directly contradicts the stated ambition to reduce and ultimately replace animal use in science, particularly when many of these tests are being conducted even when approved non-animal alternatives are available.
The government’s "Replacing Animals in Science Strategy" represents a formal acknowledgement of the need for a paradigm shift. However, the continued reliance on generic service licenses and the slow pace of transitioning to alternatives suggest a significant gap between policy statements and on-the-ground implementation. The current motion, EDM 465, seeks to bridge this gap by demanding concrete action and greater accountability in the licensing and oversight of animal experiments.
The Future of Scientific Innovation: Alternatives on the Horizon
The push to end "blind approval" of animal testing is intrinsically linked to the advancement and adoption of innovative alternatives. Scientists are increasingly developing sophisticated methods that offer greater accuracy, efficiency, and ethical integrity. The concept of a "virtual mouse," developed by scientists, exemplifies this progress. Such technologies, alongside advanced cell culture models and sophisticated computational tools, promise to revolutionize scientific research without the ethical burden of animal experimentation.
The government’s own strategy acknowledges the importance of these alternatives. However, the slow uptake indicates potential barriers, which could include funding structures, regulatory hurdles, or a reluctance to move away from established, albeit flawed, methodologies. The pressure from parliamentarians, fueled by the tireless work of organizations like Animal Aid and a growing public awareness, is crucial in accelerating this transition.
The implications of ending "blind approval" extend beyond animal welfare. A more transparent and rigorous licensing process could foster greater public trust in scientific research. It could also drive innovation by incentivizing the development and validation of cutting-edge, human-relevant research methods. As the UK navigates the complex landscape of scientific progress and ethical responsibility, the call to end "blind approval" of animal testing marks a critical juncture, demanding a future where scientific advancement is synonymous with compassion and accountability. The success of EDM 465 and the subsequent actions taken by the government will be closely watched by animal welfare advocates, scientists, and the public alike, as they collectively shape the future of scientific research in the United Kingdom.

